1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Monoclonal Antibodies 1.2.3 Vaccines 1.2.4 Cancer Growth Blockers 1.2.5 Blood Cell Growth Factors 1.3 Market by Application 1.3.1 Global Cancer Biological Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Diagnostic Laboratories 1.3.4 Research & Academic Laboratories 1.3.5 Pharmaceutical & Biotechnology Companies 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Cancer Biological Therapy Market Size (2017-2028) 2.2 Cancer Biological Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Cancer Biological Therapy Market Size by Region (2017-2022) 2.4 Global Cancer Biological Therapy Market Size Forecast by Region (2023-2028) 2.5 Global Top Cancer Biological Therapy Countries Ranking by Market Size 3 Cancer Biological Therapy Competitive by Company 3.1 Global Cancer Biological Therapy Revenue by Players 3.1.1 Global Cancer Biological Therapy Revenue by Players (2017-2022) 3.1.2 Global Cancer Biological Therapy Market Share by Players (2017-2022) 3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Cancer Biological Therapy Revenue 3.4 Global Cancer Biological Therapy Market Concentration Ratio 3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2021 3.5 Global Cancer Biological Therapy Key Players Head office and Area Served 3.6 Key Players Cancer Biological Therapy Product Solution and Service 3.7 Date of Enter into Cancer Biological Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Cancer Biological Therapy Breakdown Data by Type 4.1 Global Cancer Biological Therapy Historic Revenue by Type (2017-2022) 4.2 Global Cancer Biological Therapy Forecasted Revenue by Type (2023-2028) 5 Global Cancer Biological Therapy Breakdown Data by Application 5.1 Global Cancer Biological Therapy Historic Market Size by Application (2017-2022) 5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cancer Biological Therapy Revenue by Company (2020-2022) 6.2 North America Cancer Biological Therapy Revenue by Type (2017-2028) 6.3 North America Cancer Biological Therapy Revenue by Application (2017-2028) 6.4 North America Cancer Biological Therapy Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Cancer Biological Therapy Revenue by Company (2020-2022) 7.2 Europe Cancer Biological Therapy Revenue by Type (2017-2028) 7.3 Europe Cancer Biological Therapy Revenue by Application (2017-2028) 7.4 Europe Cancer Biological Therapy Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Cancer Biological Therapy Revenue by Company (2020-2022) 8.2 Asia Pacific Cancer Biological Therapy Revenue by Type (2017-2028) 8.3 Asia Pacific Cancer Biological Therapy Revenue by Application (2017-2028) 8.4 Asia Pacific Cancer Biological Therapy Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Cancer Biological Therapy Revenue by Company (2020-2022) 9.2 Latin America Cancer Biological Therapy Revenue by Type (2017-2028) 9.3 Latin America Cancer Biological Therapy Revenue by Application (2017-2028) 9.4 Latin America Cancer Biological Therapy Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Cancer Biological Therapy Revenue by Company (2020-2022) 10.2 Middle East and Africa Cancer Biological Therapy Revenue by Type (2017-2028) 10.3 Middle East and Africa Cancer Biological Therapy Revenue by Application (2017-2028) 10.4 Middle East and Africa Cancer Biological Therapy Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 ELI Lilly 11.1.1 ELI Lilly Company Details 11.1.2 ELI Lilly Business Overview 11.1.3 ELI Lilly Cancer Biological Therapy Products and Services 11.1.4 ELI Lilly Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.1.5 ELI Lilly Cancer Biological Therapy SWOT Analysis 11.1.6 ELI Lilly Recent Developments 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Cancer Biological Therapy Products and Services 11.2.4 Sanofi Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.2.5 Sanofi Cancer Biological Therapy SWOT Analysis 11.2.6 Sanofi Recent Developments 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Cancer Biological Therapy Products and Services 11.3.4 Merck Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.3.5 Merck Cancer Biological Therapy SWOT Analysis 11.3.6 Merck Recent Developments 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Cancer Biological Therapy Products and Services 11.4.4 Bayer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.4.5 Bayer Cancer Biological Therapy SWOT Analysis 11.4.6 Bayer Recent Developments 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Cancer Biological Therapy Products and Services 11.5.4 Roche Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.5.5 Roche Cancer Biological Therapy SWOT Analysis 11.5.6 Roche Recent Developments 11.6 Novartis International 11.6.1 Novartis International Company Details 11.6.2 Novartis International Business Overview 11.6.3 Novartis International Cancer Biological Therapy Products and Services 11.6.4 Novartis International Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.6.5 Novartis International Cancer Biological Therapy SWOT Analysis 11.6.6 Novartis International Recent Developments 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Cancer Biological Therapy Products and Services 11.7.4 Pfizer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.7.5 Pfizer Cancer Biological Therapy SWOT Analysis 11.7.6 Pfizer Recent Developments 11.8 Bristol-Myers Squibb 11.8.1 Bristol-Myers Squibb Company Details 11.8.2 Bristol-Myers Squibb Business Overview 11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Products and Services 11.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.8.5 Bristol-Myers Squibb Cancer Biological Therapy SWOT Analysis 11.8.6 Bristol-Myers Squibb Recent Developments 11.9 Seattle Genetics 11.9.1 Seattle Genetics Company Details 11.9.2 Seattle Genetics Business Overview 11.9.3 Seattle Genetics Cancer Biological Therapy Products and Services 11.9.4 Seattle Genetics Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.9.5 Seattle Genetics Cancer Biological Therapy SWOT Analysis 11.9.6 Seattle Genetics Recent Developments 11.10 Amgen 11.10.1 Amgen Company Details 11.10.2 Amgen Business Overview 11.10.3 Amgen Cancer Biological Therapy Products and Services 11.10.4 Amgen Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.10.5 Amgen Cancer Biological Therapy SWOT Analysis 11.10.6 Amgen Recent Developments 11.11 Takeda Pharmaceuticals 11.11.1 Takeda Pharmaceuticals Company Details 11.11.2 Takeda Pharmaceuticals Business Overview 11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Products and Services 11.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.11.5 Takeda Pharmaceuticals Recent Developments 11.12 GlaxoSmithKline 11.12.1 GlaxoSmithKline Company Details 11.12.2 GlaxoSmithKline Business Overview 11.12.3 GlaxoSmithKline Cancer Biological Therapy Products and Services 11.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.12.5 GlaxoSmithKline Recent Developments 11.13 Spectrum Pharmaceuticals 11.13.1 Spectrum Pharmaceuticals Company Details 11.13.2 Spectrum Pharmaceuticals Business Overview 11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Products and Services 11.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.13.5 Spectrum Pharmaceuticals Recent Developments 11.14 Celgene Corporation 11.14.1 Celgene Corporation Company Details 11.14.2 Celgene Corporation Business Overview 11.14.3 Celgene Corporation Cancer Biological Therapy Products and Services 11.14.4 Celgene Corporation Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.14.5 Celgene Corporation Recent Developments 11.15 AstraZeneca, Plc. 11.15.1 AstraZeneca, Plc. Company Details 11.15.2 AstraZeneca, Plc. Business Overview 11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Products and Services 11.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.15.5 AstraZeneca, Plc. Recent Developments 11.16 Otsuka 11.16.1 Otsuka Company Details 11.16.2 Otsuka Business Overview 11.16.3 Otsuka Cancer Biological Therapy Products and Services 11.16.4 Otsuka Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.16.5 Otsuka Recent Developments 11.17 Eisai 11.17.1 Eisai Company Details 11.17.2 Eisai Business Overview 11.17.3 Eisai Cancer Biological Therapy Products and Services 11.17.4 Eisai Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.17.5 Eisai Recent Developments 11.18 Abbvie 11.18.1 Abbvie Company Details 11.18.2 Abbvie Business Overview 11.18.3 Abbvie Cancer Biological Therapy Products and Services 11.18.4 Abbvie Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.18.5 Abbvie Recent Developments 11.19 Incyte 11.19.1 Incyte Company Details 11.19.2 Incyte Business Overview 11.19.3 Incyte Cancer Biological Therapy Products and Services 11.19.4 Incyte Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) 11.19.5 Incyte Recent Developments 12 Cancer Biological Therapy Market Dynamics 12.1 Cancer Biological Therapy Market Trends 12.2 Cancer Biological Therapy Market Drivers 12.3 Cancer Biological Therapy Market Challenges 12.4 Cancer Biological Therapy Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Cancer Biological Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Vaccines Table 4. Key Players of Cancer Growth Blockers Table 5. Key Players of Blood Cell Growth Factors Table 6. Global Cancer Biological Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Cancer Biological Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 8. Global Cancer Biological Therapy Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Cancer Biological Therapy Revenue Market Share by Region (2017-2022) Table 10. Global Cancer Biological Therapy Revenue by Players (2017-2022) & (US$ Million) Table 11. Global Cancer Biological Therapy Market Share by Players (2017-2022) Table 12. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021) Table 13. Ranking of Global Top Cancer Biological Therapy Companies by Revenue (US$ Million) in 2021 Table 14. Global 5 Largest Players Market Share by Cancer Biological Therapy Revenue (CR5 and HHI) & (2017-2022) Table 15. Key Players Headquarters and Area Served Table 16. Key Players Cancer Biological Therapy Product Solution and Service Table 17. Date of Key Manufacturers Enter into Cancer Biological Therapy Market Table 18. Mergers & Acquisitions, Expansion Plans Table 19. Global Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million) Table 20. Global Cancer Biological Therapy Revenue Market Share by Type (2017-2022) Table 21. Global Cancer Biological Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 22. Global Cancer Biological Therapy Revenue Market Share by Type (2023-2028) Table 23. Global Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million) Table 24. Global Cancer Biological Therapy Revenue Market Share by Application (2017-2022) Table 25. Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 26. Global Cancer Biological Therapy Revenue Market Share by Application (2023-2028) Table 27. North America Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million) Table 28. North America Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million) Table 29. North America Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million) Table 30. North America Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million) Table 31. North America Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million) Table 32. North America Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million) Table 33. North America Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million) Table 34. Europe Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million) Table 35. Europe Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million) Table 36. Europe Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million) Table 37. Europe Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million) Table 38. Europe Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million) Table 39. Europe Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million) Table 40. Europe Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million) Table 41. Asia Pacific Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million) Table 42. Asia Pacific Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million) Table 43. Asia Pacific Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million) Table 44. Asia Pacific Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million) Table 45. Asia Pacific Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million) Table 46. Asia Pacific Cancer Biological Therapy Revenue by Region (2017-2022) & (US$ Million) Table 47. Asia Pacific Cancer Biological Therapy Revenue by Region (2023-2028) & (US$ Million) Table 48. Latin America Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million) Table 49. Latin America Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million) Table 50. Latin America Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million) Table 51. Latin America Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million) Table 52. Latin America Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million) Table 53. Latin America Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million) Table 54. Latin America Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Cancer Biological Therapy Revenue by Company (2020-2022) & (US$ Million) Table 56. Middle East and Africa Cancer Biological Therapy Revenue by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Cancer Biological Therapy Revenue by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Cancer Biological Therapy Revenue by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Cancer Biological Therapy Revenue by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Cancer Biological Therapy Revenue by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Cancer Biological Therapy Revenue by Country (2023-2028) & (US$ Million) Table 62. ELI Lilly Company Details Table 63. ELI Lilly Business Overview Table 64. ELI Lilly Cancer Biological Therapy Product and Services Table 65. ELI Lilly Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 66. ELI Lilly Cancer Biological Therapy SWOT Analysis Table 67. ELI Lilly Recent Developments Table 68. Sanofi Company Details Table 69. Sanofi Business Overview Table 70. Sanofi Cancer Biological Therapy Product and Services Table 71. Sanofi Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 72. Sanofi Cancer Biological Therapy SWOT Analysis Table 73. Sanofi Recent Developments Table 74. Merck Company Details Table 75. Merck Business Overview Table 76. Merck Cancer Biological Therapy Product and Services Table 77. Merck Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 78. Merck Cancer Biological Therapy SWOT Analysis Table 79. Merck Recent Developments Table 80. Bayer Company Details Table 81. Bayer Business Overview Table 82. Bayer Cancer Biological Therapy Product and Services Table 83. Bayer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 84. Bayer Cancer Biological Therapy SWOT Analysis Table 85. Bayer Recent Developments Table 86. Roche Company Details Table 87. Roche Business Overview Table 88. Roche Cancer Biological Therapy Product and Services Table 89. Roche Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 90. Roche Cancer Biological Therapy SWOT Analysis Table 91. Roche Recent Developments Table 92. Novartis International Company Details Table 93. Novartis International Business Overview Table 94. Novartis International Cancer Biological Therapy Product and Services Table 95. Novartis International Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 96. Novartis International Cancer Biological Therapy SWOT Analysis Table 97. Novartis International Recent Developments Table 98. Pfizer Company Details Table 99. Pfizer Business Overview Table 100. Pfizer Cancer Biological Therapy Product and Services Table 101. Pfizer Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 102. Pfizer Cancer Biological Therapy SWOT Analysis Table 103. Pfizer Recent Developments Table 104. Bristol-Myers Squibb Company Details Table 105. Bristol-Myers Squibb Business Overview Table 106. Bristol-Myers Squibb Cancer Biological Therapy Product and Services Table 107. Bristol-Myers Squibb Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 108. Bristol-Myers Squibb Cancer Biological Therapy SWOT Analysis Table 109. Bristol-Myers Squibb Recent Developments Table 110. Seattle Genetics Company Details Table 111. Seattle Genetics Business Overview Table 112. Seattle Genetics Cancer Biological Therapy Product and Services Table 113. Seattle Genetics Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 114. Seattle Genetics Cancer Biological Therapy SWOT Analysis Table 115. Seattle Genetics Recent Developments Table 116. Amgen Company Details Table 117. Amgen Business Overview Table 118. Amgen Cancer Biological Therapy Product and Services Table 119. Amgen Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 120. Amgen Cancer Biological Therapy SWOT Analysis Table 121. Amgen Recent Developments Table 122. Takeda Pharmaceuticals Company Details Table 123. Takeda Pharmaceuticals Business Overview Table 124. Takeda Pharmaceuticals Cancer Biological Therapy Product and Services Table 125. Takeda Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 126. Takeda Pharmaceuticals Recent Developments Table 127. GlaxoSmithKline Company Details Table 128. GlaxoSmithKline Business Overview Table 129. GlaxoSmithKline Cancer Biological Therapy Product and Services Table 130. GlaxoSmithKline Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 131. GlaxoSmithKline Recent Developments Table 132. Spectrum Pharmaceuticals Company Details Table 133. Spectrum Pharmaceuticals Business Overview Table 134. Spectrum Pharmaceuticals Cancer Biological Therapy Product and Services Table 135. Spectrum Pharmaceuticals Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 136. Spectrum Pharmaceuticals Recent Developments Table 137. Celgene Corporation Company Details Table 138. Celgene Corporation Business Overview Table 139. Celgene Corporation Cancer Biological Therapy Product and Services Table 140. Celgene Corporation Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 141. Celgene Corporation Recent Developments Table 142. AstraZeneca, Plc. Company Details Table 143. AstraZeneca, Plc. Business Overview Table 144. AstraZeneca, Plc. Cancer Biological Therapy Product and Services Table 145. AstraZeneca, Plc. Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 146. AstraZeneca, Plc. Recent Developments Table 147. Otsuka Company Details Table 148. Otsuka Business Overview Table 149. Otsuka Cancer Biological Therapy Product and Services Table 150. Otsuka Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 151. Otsuka Recent Developments Table 152. Eisai Company Details Table 153. Eisai Business Overview Table 154. Eisai Cancer Biological Therapy Product and Services Table 155. Eisai Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 156. Eisai Recent Developments Table 157. Abbvie Company Details Table 158. Abbvie Business Overview Table 159. Abbvie Cancer Biological Therapy Product and Services Table 160. Abbvie Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 161. Abbvie Recent Developments Table 162. Incyte Company Details Table 163. Incyte Business Overview Table 164. Incyte Cancer Biological Therapy Product and Services Table 165. Incyte Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Table 166. Incyte Recent Developments Table 167. Cancer Biological Therapy Market Trends Table 168. Cancer Biological Therapy Market Drivers Table 169. Cancer Biological Therapy Market Challenges Table 170. Cancer Biological Therapy Market Restraints Table 171. Research Programs/Design for This Report Table 172. Key Data Information from Secondary Sources Table 173. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Biological Therapy Sales Market Share by Type: 2021 VS 2028 Figure 2. Monoclonal Antibodies Features Figure 3. Vaccines Features Figure 4. Cancer Growth Blockers Features Figure 5. Blood Cell Growth Factors Features Figure 6. Global Cancer Biological Therapy Sales Market Share by Application: 2021 VS 2028 Figure 7. Hospitals Case Studies Figure 8. Diagnostic Laboratories Case Studies Figure 9. Research & Academic Laboratories Case Studies Figure 10. Pharmaceutical & Biotechnology Companies Case Studies Figure 11. Cancer Biological Therapy Report Years Considered Figure 12. Global Cancer Biological Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Cancer Biological Therapy Market Size 2017-2028 (US$ Million) Figure 14. Global Cancer Biological Therapy Market Size Market Share by Region: 2021 VS 2028 Figure 15. Global Cancer Biological Therapy Revenue Market Share by Region in 2017 VS 2022 Figure 16. Global Top 10 Cancer Biological Therapy Countries Ranking by Market Size (US$ Million) in 2021 Figure 17. Global Cancer Biological Therapy Market Share by Players in 2021 Figure 18. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2021 Figure 20. North America Cancer Biological Therapy Revenue Market Share by Company in 2021 Figure 21. North America Cancer Biological Therapy Revenue Market Share by Type (2017-2028) Figure 22. North America Cancer Biological Therapy Revenue Market Share by Application (2017-2028) Figure 23. North America Cancer Biological Therapy Revenue Share by Country (2017-2028) Figure 24. U.S. Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 25. Canada Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 26. Europe Cancer Biological Therapy Revenue Market Share by Company in 2021 Figure 27. Europe Cancer Biological Therapy Revenue Market Share by Type (2017-2028) Figure 28. Europe Cancer Biological Therapy Revenue Market Share by Application (2017-2028) Figure 29. Europe Cancer Biological Therapy Revenue Share by Country (2017-2028) Figure 30. Germany Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 31. France Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 32. U.K. Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 33. Italy Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 34. Russia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 35. Asia Pacific Cancer Biological Therapy Revenue Market Share by Company in 2021 Figure 36. Asia Pacific Cancer Biological Therapy Revenue Market Share by Type (2017-2028) Figure 37. Asia Pacific Cancer Biological Therapy Revenue Market Share by Application (2017-2028) Figure 38. Asia Pacific Cancer Biological Therapy Revenue Share by Region (2017-2028) Figure 39. China Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 40. Japan Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 41. South Korea Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 42. India Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 43. Australia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 44. Taiwan Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 45. Indonesia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 46. Thailand Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 47. Malaysia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 48. Philippines Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 49. Vietnam Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 50. Latin America Cancer Biological Therapy Revenue Market Share by Company in 2021 Figure 51. Latin America Cancer Biological Therapy Revenue Market Share by Type (2017-2028) Figure 52. Latin America Cancer Biological Therapy Revenue Market Share by Application (2017-2028) Figure 53. Latin America Cancer Biological Therapy Revenue Share by Country (2017-2028) Figure 54. Mexico Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 55. Brazil Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 56. Argentina Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 57. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Company in 2021 Figure 58. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Type (2017-2028) Figure 59. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Application (2017-2028) Figure 60. Middle East and Africa Cancer Biological Therapy Revenue Share by Country (2017-2028) Figure 61. Turkey Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 62. Saudi Arabia Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 63. U.A.E Cancer Biological Therapy Revenue (2017-2028) & (US$ Million) Figure 64. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 65. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 66. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 67. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 68. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 69. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 70. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 72. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 73. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 74. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 75. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 76. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 77. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 78. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 79. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 80. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 81. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 82. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022) Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

ELI Lilly Sanofi Merck Bayer Roche Novartis International Pfizer Bristol-Myers Squibb Seattle Genetics Amgen Takeda Pharmaceuticals GlaxoSmithKline Spectrum Pharmaceuticals Celgene Corporation AstraZeneca, Plc. Otsuka Eisai Abbvie Incyte